白介素-21对ige介导的过敏反应的有效抑制作用

T. Kishida, Y. Hiromura, T. Hama, J. Imanishi, Y. Hisa, O. Mazda
{"title":"白介素-21对ige介导的过敏反应的有效抑制作用","authors":"T. Kishida, Y. Hiromura, T. Hama, J. Imanishi, Y. Hisa, O. Mazda","doi":"10.1109/MHS.2007.4420871","DOIUrl":null,"url":null,"abstract":"IgE plays essential roles in the pathogenesis of many allergic disorders including bronchial asthma, allergic rhinitis, atopic dermatitis, and anaphylaxis. If IgE production can be effectively and safely controlled in patients, such procedures may alleviate allergic symptoms, leading to novel therapeutic and prophylactic interventions of allergic diseases. Interleukin-21 (IL-21) is a cytokine produced by activated T cells. It exerts pleiotrophic immunomodulatory functions through acting on various immune cells including T, B, and NK cells. To analyze influence of exogenous IL-21 in vivo, we inserted an expression unit of IL-21 cDNA into an Epstein-Barr virus (EBV)-based artificial chromosome, so that extremely powerful and long-lasting expression of the cytokine can be achieved in vivo in the liver. Peanut anaphylactic mice were established by repetitive immunization with the crude peanut extract (CPE) as an allergen, and they received intravenous administration of the DNA construct through the tail vein under high pressure. As the results, anaphylactic symptoms were completely abrogated by the IL-21 gene treatment, in striking contrast to untreated allergic mice that showed extremely severe systemic disturbance. Serum level of IgE was also drastically suppressed by IL-21 gene treatment. Then we used recombinant IL-21 (rIL-21) to treat anaphylactic as well as allergic rhinitis mice, which also showed significant remission of the diseases. As the mechanisms of the IgE regulation, we found that expression of germ line Cepsiv transcript was suppressed in B cells that were treated with rIL-21 in vitro or in vivo, suggesting that IL-21 effectively suppressed the class switch recombination (CSR) to IgE. The present findings strongly suggest that IL-21 can be used as a novel molecular medicine to control allergy. It was also shown that the EBV-based artificial chromosome provides a useful means to analyze bioactivity in vivo of various genes in mammals, providing a platform to investigate functions of genes as well as to discover promising molecules for therapeutic molecular targeting to treat various disorders.","PeriodicalId":161669,"journal":{"name":"2007 International Symposium on Micro-NanoMechatronics and Human Science","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interleukin-21 as an Effective Suppressant for IgE-mediated Allergic Hypersensitivity Reactions\",\"authors\":\"T. Kishida, Y. Hiromura, T. Hama, J. Imanishi, Y. Hisa, O. Mazda\",\"doi\":\"10.1109/MHS.2007.4420871\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IgE plays essential roles in the pathogenesis of many allergic disorders including bronchial asthma, allergic rhinitis, atopic dermatitis, and anaphylaxis. If IgE production can be effectively and safely controlled in patients, such procedures may alleviate allergic symptoms, leading to novel therapeutic and prophylactic interventions of allergic diseases. Interleukin-21 (IL-21) is a cytokine produced by activated T cells. It exerts pleiotrophic immunomodulatory functions through acting on various immune cells including T, B, and NK cells. To analyze influence of exogenous IL-21 in vivo, we inserted an expression unit of IL-21 cDNA into an Epstein-Barr virus (EBV)-based artificial chromosome, so that extremely powerful and long-lasting expression of the cytokine can be achieved in vivo in the liver. Peanut anaphylactic mice were established by repetitive immunization with the crude peanut extract (CPE) as an allergen, and they received intravenous administration of the DNA construct through the tail vein under high pressure. As the results, anaphylactic symptoms were completely abrogated by the IL-21 gene treatment, in striking contrast to untreated allergic mice that showed extremely severe systemic disturbance. Serum level of IgE was also drastically suppressed by IL-21 gene treatment. Then we used recombinant IL-21 (rIL-21) to treat anaphylactic as well as allergic rhinitis mice, which also showed significant remission of the diseases. As the mechanisms of the IgE regulation, we found that expression of germ line Cepsiv transcript was suppressed in B cells that were treated with rIL-21 in vitro or in vivo, suggesting that IL-21 effectively suppressed the class switch recombination (CSR) to IgE. The present findings strongly suggest that IL-21 can be used as a novel molecular medicine to control allergy. It was also shown that the EBV-based artificial chromosome provides a useful means to analyze bioactivity in vivo of various genes in mammals, providing a platform to investigate functions of genes as well as to discover promising molecules for therapeutic molecular targeting to treat various disorders.\",\"PeriodicalId\":161669,\"journal\":{\"name\":\"2007 International Symposium on Micro-NanoMechatronics and Human Science\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2007 International Symposium on Micro-NanoMechatronics and Human Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/MHS.2007.4420871\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2007 International Symposium on Micro-NanoMechatronics and Human Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/MHS.2007.4420871","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

IgE在包括支气管哮喘、过敏性鼻炎、特应性皮炎和过敏反应在内的许多过敏性疾病的发病机制中起着重要作用。如果能够有效和安全地控制患者的IgE产生,这些程序可能会减轻过敏症状,导致过敏性疾病的新型治疗和预防干预。白细胞介素-21 (IL-21)是由活化的T细胞产生的细胞因子。它通过作用于T、B、NK等多种免疫细胞发挥多营养免疫调节功能。为了分析外源IL-21在体内的影响,我们将IL-21 cDNA的表达单元插入到eb病毒(EBV)人工染色体中,从而在肝脏内实现了IL-21的强大而持久的体内表达。以花生粗提取物(CPE)作为过敏原,通过重复免疫建立花生过敏小鼠,并在高压下通过尾静脉静脉给药。结果显示,IL-21基因治疗完全消除了过敏症状,与未治疗的过敏小鼠表现出极其严重的全身紊乱形成鲜明对比。IL-21基因处理也显著抑制血清IgE水平。然后我们用重组IL-21 (IL-21)治疗过敏性鼻炎和变应性鼻炎小鼠,也显示出明显的疾病缓解。作为IgE调控的机制,我们发现在体外和体内经IL-21处理的B细胞中,种系Cepsiv转录物的表达被抑制,这表明IL-21有效地抑制了类开关重组(CSR)到IgE的表达。本研究结果强烈提示IL-21可作为一种新型的分子药物来控制过敏。研究还表明,基于ebv的人工染色体为分析哺乳动物体内各种基因的生物活性提供了一种有用的手段,为研究基因的功能以及发现治疗性分子靶向治疗各种疾病提供了一个平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Interleukin-21 as an Effective Suppressant for IgE-mediated Allergic Hypersensitivity Reactions
IgE plays essential roles in the pathogenesis of many allergic disorders including bronchial asthma, allergic rhinitis, atopic dermatitis, and anaphylaxis. If IgE production can be effectively and safely controlled in patients, such procedures may alleviate allergic symptoms, leading to novel therapeutic and prophylactic interventions of allergic diseases. Interleukin-21 (IL-21) is a cytokine produced by activated T cells. It exerts pleiotrophic immunomodulatory functions through acting on various immune cells including T, B, and NK cells. To analyze influence of exogenous IL-21 in vivo, we inserted an expression unit of IL-21 cDNA into an Epstein-Barr virus (EBV)-based artificial chromosome, so that extremely powerful and long-lasting expression of the cytokine can be achieved in vivo in the liver. Peanut anaphylactic mice were established by repetitive immunization with the crude peanut extract (CPE) as an allergen, and they received intravenous administration of the DNA construct through the tail vein under high pressure. As the results, anaphylactic symptoms were completely abrogated by the IL-21 gene treatment, in striking contrast to untreated allergic mice that showed extremely severe systemic disturbance. Serum level of IgE was also drastically suppressed by IL-21 gene treatment. Then we used recombinant IL-21 (rIL-21) to treat anaphylactic as well as allergic rhinitis mice, which also showed significant remission of the diseases. As the mechanisms of the IgE regulation, we found that expression of germ line Cepsiv transcript was suppressed in B cells that were treated with rIL-21 in vitro or in vivo, suggesting that IL-21 effectively suppressed the class switch recombination (CSR) to IgE. The present findings strongly suggest that IL-21 can be used as a novel molecular medicine to control allergy. It was also shown that the EBV-based artificial chromosome provides a useful means to analyze bioactivity in vivo of various genes in mammals, providing a platform to investigate functions of genes as well as to discover promising molecules for therapeutic molecular targeting to treat various disorders.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信